Factors associated with 24-hour urinary volume: The Swiss salt survey

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Schoen, Tobias ^a   Blum, Jonas ^a   Paccaud, Fred ^b   Burnier, Michel ^c   Bochud, Murielle ^b   Conen, David ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Daily urinary volume; Gender; Kidney function; Population based study; Prevention; Salt; Salt excretion

Indexed keywords

ALCOHOL; CREATININE; SODIUM;

24 HOUR URINE VOLUME; ADULT; ALCOHOL CONSUMPTION; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; FEMALE; FLUID INTAKE; FOOD INTAKE; FRUIT; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAT; MULTICENTER STUDY; NEPHROLITHIASIS; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKING; SODIUM EXCRETION; SODIUM URINE LEVEL; SWITZERLAND; URINE VOLUME; VEGETABLE;

ADULT; AGE DISTRIBUTION; BIOLOGICAL MARKERS; DATA COLLECTION; DIET SURVEYS; FEMALE; FOOD PREFERENCES; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SODIUM CHLORIDE, DIETARY; SWITZERLAND;

EID: 84887837280     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-246     Document Type: Review

References (25)

1. The impact of CKD identification in large countries: the burden of illness. Jha V, Wang AY-M, Wang H, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc-Eur Ren Assoc 2012 27 Suppl 3 ii32 iii38
2. Chronic kidney disease. Levey AS, Coresh J, Lancet 2012 379 165 180 10.1016/S0140-6736(11)60178-5 21840587
3. Urine volume and change in estimated GFR in a community-based cohort study. Clark WF, Sontrop JM, Macnab JJ, Suri RS, Moist L, Salvadori M, Garg AX, Clin J Am Soc Nephrol CJASN 2011 6 2634 2641 10.2215/CJN.01990211
4. Gender differences in seasonal variation of urine stone risk factors. Parks JH, Barsky R, Coe FL, J Urol 2003 170 2 Pt 1 384 388 12853781 (Pubitemid 36870206)
5. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P, Kidney Int 2005 67 1934 1943 10.1111/j.1523-1755.2005.00292.x 15840041 (Pubitemid 40577729)
6. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Perucca J, Bouby N, Valeix P, Bankir L, Am J Physiol Regul Integr Comp Physiol 2007 292 700 R705 16990487
7. Vitamin D levels and associated factors: a population-based study in Switzerland. Guessous I, Dudler V, Glatz N, Theler JM, Zoller O, Paccaud F, Burnier M, Bochud M, Swiss Med Wkly 2012 142 0 23188555
8. Fluid and nutrient intake and risk of chronic kidney disease. Strippoli GFM, Craig JC, Rochtchina E, Flood VM, Wang JJ, Mitchell P, Nephrol Carlton Vic 2011 16 326 334 10.1111/j.1440-1797.2010.01415.x
9. High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Hebert LA, Greene T, Levey A, Falkenhain ME, Klahr S, Am J Kidney Dis Off J Natl Kidney Found 2003 41 962 971 10.1016/S0272- 6386(03)00193-8 (Pubitemid 36532130)
10. My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney disease. Wenzel UO, Hebert LA, Stahl RAK, Krenz I, Clin J Am Soc Nephrol CJASN 2006 1 344 346 10.2215/CJN.01140905
11. A case for water in the treatment of polycystic kidney disease. Torres VE, Bankir L, Grantham JJ, Clin J Am Soc Nephrol CJASN 2009 4 1140 1150 10.2215/CJN.00790209
12. Tolvaptan in patients with autosomal dominant polycystic kidney disease. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, N Engl J Med 2012 367 2407 2418 10.1056/NEJMoa1205511 23121377
13. Increased water intake decreases progression of polycystic kidney disease in the PCK rat. Nagao S, Nishii K, Katsuyama M, Kurahashi H, Marunouchi T, Takahashi H, Wallace DP, J Am Soc Nephrol JASN 2006 17 2220 2227 10.1681/ASN.2006030251 (Pubitemid 44141912)
14. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. Wang X, Gattone V 2nd, Harris PC, Torres VE, J Am Soc Nephrol JASN 2005 16 846 851 10.1681/ASN.2004121090 (Pubitemid 41710293)
15. Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness. Lotan Y, Buendia Jiménez I, Lenoir-Wijnkoop I, Daudon M, Molinier L, Tack I, Nuijten MJC, J Urol 2013 189 935 939 10.1016/j.juro.2012.08.254 23017509
16. Treatment and prevention of kidney stones: an update. Frassetto L, Kohlstadt I, Am Fam Physician 2011 84 1234 1242 22150656
17. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Arnlöv J, Ingelsson E, Sundström J, Lind L, Circulation 2010 121 230 236 10.1161/CIRCULATIONAHA. 109.887521 20038741
18. Smoking and cardiovascular disease. Lakier JB, Am J Med 1992 93 8S 12S 10.1016/0002-9343(92)90620-Q 1497005
19. Dietary intake of saturated fat by food source and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. De Oliveira Otto MC, Mozaffarian D, Kromhout D, Bertoni AG, Sibley CT, Jacobs DR Jr, Nettleton JA, Am J Clin Nutr 2012 96 397 404 10.3945/ajcn.112.037770 22760560
20. Kidney stone disease and risk factors for coronary heart disease. Hamano S, Nakatsu H, Suzuki N, Tomioka S, Tanaka M, Murakami S, Int J Urol Off J Jpn Urol Assoc 2005 12 859 863 (Pubitemid 41726955)
21. Urine concentrating and diluting ability during aging. Sands JM, J Gerontol A Biol Sci Med Sci 2012 67 1352 1357 10.1093/gerona/gls128 22588950
22. Effect of salt intake on renal excretion of water in humans. He FJ, Markandu ND, Sagnella GA, MacGregor GA, Hypertension 2001 38 317 320 10.1161/01.HYP.38.3.317 11566897 (Pubitemid 34225658)
23. Ethanol reduces vasopressin release by inhibiting calcium currents in nerve terminals. Wang XM, Lemos JR, Dayanithi G, Nordmann JJ, Treistman SN, Brain Res 1991 551 338 341 10.1016/0006-8993(91)90954-T 1913165
24. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers. Massey LK, Sutton RAL, J Urol 2004 172 555 558 10.1097/01.ju.0000129413.87024.5c 15247728 (Pubitemid 38900202)
25. A comparison between the lifestyles of men and women-parents of school age children. Fiala J, Brázdová Z, Cent Eur J Public Health 2000 8 94 100 10857046 (Pubitemid 30255512)